gIII antibody responses in pigs following vaccination and challenge to Aujeszky's disease

Serological responses to a genetically engineered Aujeszky's disease “marker” vaccine (dl gIII + dl tk) were monitored using a blocking-ELISA (B-ELISA), a serum neutralisation test (SNT) and an indirect ELISA (I-ELISA). The B-ELISA is capable of differentiating pigs vaccinated with the above va...

Full description

Saved in:
Bibliographic Details
Published inVeterinary microbiology Vol. 27; no. 2; pp. 197 - 201
Main Authors Motha, M.X.Julian, Ralston, Jacqueline C.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 1991
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Serological responses to a genetically engineered Aujeszky's disease “marker” vaccine (dl gIII + dl tk) were monitored using a blocking-ELISA (B-ELISA), a serum neutralisation test (SNT) and an indirect ELISA (I-ELISA). The B-ELISA is capable of differentiating pigs vaccinated with the above vaccine from natural infection. The SNT and the I-ELISA indicated that the pigs responded to vaccination and challenge. All three tests showed that the controls and the in-contact pigs always reacted negative for antibodies. The B-ELISA was able to detect pigs challenged with a field isolate 24 days post-challenge. These pigs remained positive until 110 days post-challenge when last tested. These findings indicate that the B-ELISA could be used successfully with this vaccine in a control eradication programme. This trial also shows that the vaccine virus did not spread to the in-contact pigs and also the vaccinated and challenged pigs did not transmit the disease to other susceptible pigs when they were introduced 14 days after challenge.
Bibliography:L73
9105624
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0378-1135
1873-2542
DOI:10.1016/0378-1135(91)90011-4